Royal Bank of Canada
PLRX icon

Royal Bank of Canada’s Pliant Therapeutics PLRX Stock Holding History

Royal Bank of Canada’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Sell
997
-188
-16% -$237 ﹤0.01% 6743
2025
Q4 		$2K Sell
1,185
-14,990
-93% -$22.5K ﹤0.01% 6921
2025
Q3 		$24K Sell
16,175
-28,457
-64% -$43.4K ﹤0.01% 6139
2025
Q2 		$51K Sell
44,632
-318,070
-88% -$449K ﹤0.01% 5914
2025
Q1 		$491K Buy
362,702
+250,185
+222% +$1.52M ﹤0.01% 4017
2024
Q4 		$1.48M Buy
112,517
+6,947
+7% +$94.8K ﹤0.01% 3239
2024
Q3 		$1.18M Buy
105,570
+53,530
+103% +$670K ﹤0.01% 3399
2024
Q2 		$560K Buy
52,040
+4,734
+10% +$61K ﹤0.01% 3927
2024
Q1 		$704K Sell
47,306
-18,581
-28% -$306K ﹤0.01% 3735
2023
Q4 		$1.19M Buy
65,887
+13,436
+26% +$204K ﹤0.01% 3524
2023
Q3 		$910K Buy
52,451
+13,155
+33% +$228K ﹤0.01% 3518
2023
Q2 		$712K Sell
39,296
-21,329
-35% -$505K ﹤0.01% 3660
2023
Q1 		$1.61M Buy
60,625
+38,466
+174% +$1.1M ﹤0.01% 2969
2022
Q4 		$428K Buy
22,159
+2,339
+12% +$48.9K ﹤0.01% 4249
2022
Q3 		$415K Buy
19,820
+19,551
+7,268% +$374K ﹤0.01% 4180
2022
Q2 		$2K Sell
269
-1,396
-84% -$8.94K ﹤0.01% 6983
2022
Q1 		$11K Sell
1,665
-3,630
-69% -$37K ﹤0.01% 6911
2021
Q4 		$71K Buy
5,295
+2,905
+122% +$46.2K ﹤0.01% 6172
2021
Q3 		$40K Buy
2,390
+743
+45% +$15.8K ﹤0.01% 6293
2021
Q2 		$48K Sell
1,647
-481
-23% -$15K ﹤0.01% 6073
2021
Q1 		$84K Buy
2,128
+1,899
+829% +$61.7K ﹤0.01% 5575
2020
Q4 		$5K Buy
+229
New +$5.74K ﹤0.01% 6645

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Royal Bank of Canada's PLRX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Pliant Therapeutics (PLRX) stake by 16% in Q1 2026, selling an estimated $237 and leaving 997 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6743.

Royal Bank of Canada first reported a position in PLRX in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.61M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Royal Bank of Canada held 997 shares of Pliant Therapeutics worth $2K as of Q1 2026.
  • Royal Bank of Canada sold 188 Pliant Therapeutics shares in Q1 2026, an estimated $237.
  • Pliant Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6743 holding.
  • Royal Bank of Canada first reported a position in Pliant Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's Pliant Therapeutics position peaked at $1.61M in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.